Syneos Health_rgb_r.jpg
Syneos Health Launches “Lab to Life” Enterprise Partnership with Komodo Health
May 03, 2021 07:00 ET | Syneos Health, Inc.
MORRISVILLE, N.C., May 03, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, announced today it has expanded its relationship...
Beroni Logo @ Dec 2019.png
Beroni Group’s SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) Has Received Export Permit
April 27, 2021 08:30 ET | Beroni Group Limited
NEW YORK and SYDNEY, Australia, April 27, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise...
Cellectis Logo.png
Cellectis’ Annual Shareholders’ General Meeting to be Held on June 1, 2021
April 26, 2021 16:39 ET | Cellectis Inc.
NEW YORK, April 26, 2021 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS). Dear Shareholders, In the context of the Covid-19 pandemic and in accordance with Ordinance no....
Genovac Antibody Discovery Launches in NDSU Research and Technology Park
April 26, 2021 12:59 ET | Genovac
Fargo, North Dakota, April 26, 2021 (GLOBE NEWSWIRE) -- Genovac Antibody Discovery has launched in the United States following a management buyout of an antibody discovery business unit owned by...
sitryx-no-molecule-no-i-wb.png
Sitryx further strengthens leadership team with the appointment of Iain Kilty, Ph.D., as Chief Scientific Officer
April 15, 2021 02:00 ET | Sitryx Therapeutics
Sitryx further strengthens leadership team with the appointment of Iain Kilty, Ph.D., as Chief Scientific Officer Oxford, UK – 15 April 2021 – Sitryx (“the Company”), a biopharmaceutical company...
Cellectis Logo.png
Monthly information on share capital and company voting rights
April 12, 2021 16:30 ET | Cellectis Inc.
(Article 223-16 of General Regulation of the French financial markets authority) NEW YORK, April 12, 2021 (GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN code: FR0010425595 DateTotal...
Dynamic Global Events logo.png
InvestorBrandNetwork (IBN) and BioMedWire (BMW) Announce Collaboration with Dynamic Global Events (DGE) to Serve as Official Media Partners for Upcoming 2021 Events
April 12, 2021 09:35 ET | Dynamic Global Events
LOS ANGELES, April 12, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- InvestorBrandNetwork (“IBN”), a multifaceted communications organization engaged in connecting companies to the investment...
TreviLogo.png
Trevi Therapeutics to Present at 20th Annual Needham Virtual Healthcare Conference
April 07, 2021 07:30 ET | Trevi Therapeutics
NEW HAVEN, Conn., April 07, 2021 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company focused on the development and commercialization of Haduvio™...
ARC logo.png
Biopharmaceutical Market Value Predicted To Reach US$ 535 Billion By 2027: Acumen Research And Consulting
March 30, 2021 12:23 ET | Acumen Research and Consulting
LOS ANGELES, March 30, 2021 (GLOBE NEWSWIRE) -- The Global Biopharmaceutical Market is expected to grow at a CAGR of around 7.3% from 2020 to 2027 and reach the market value of over US$ 535 Bn by...
TreviLogo.png
Trevi Therapeutics Announces Fourth Quarter and Year End 2020 Financial Results and Business Updates
March 25, 2021 16:05 ET | Trevi Therapeutics
Expects to Complete Enrollment and Report Top-Line Data of the Phase 2b/3 PRISM Trial in Second Half of 2021 Cash Position Expected to Fund Operations into the Second Quarter of 2022 NEW...